Skip to main content
Helmholtz Munich | ©Petra Nehmeyer

Dr. Julia Hess

Head of competence field “Therapeutic Targets and Intervention”
+49 89 3187 3517Email meBuilding/Room: 57/031

Academic Career and Research Areas

 

Julia Hess is a biologist working in translational oncology and acting as a link between the research unit and clinical partners.

She leads the competence field “Therapeutic Targets and Intervention” in the research unit Radiation Cytogenetics (ZYTO) with a focus on generating clinical cohorts of cancer patients and omics data at multiple levels to identify prognostic stratification markers and develop targets for novel therapeutic approaches in precision oncology.

Julia Hess is currently completing her habilitation at the Medical Faculty of the LMU.

 

Fields of Work and Expertise

translational oncologymolecular mechanisms prognostic stratification markers therapeutic targets and intervention head and neck cancer clinical cohorts: biometerial, clinical data, multi-omics data cancer cell culture models

Publications

read more

2022 Cancers https:// doi.org/10.3390/cancers14153745

Hess J, Unger K, Maihoefer C, Schüttrumpf L, Weber P, Marschner S, Wintergerst L, Pflugradt L, Baumeister P, Walch A, Woischke C, Kirchner T, Werner M, Sörensen K, Baumann M, Tinhofer I, Combs SE, Debus J, Schäfer H, Krause M, Linge A, von der Grün J, Stuschke M, Zips D, Canis M, Lauber K, Ganswindt U, Henke M, Zitzelsberger H, Belka C

Integration of p16/HPV DNA status with a 24-miRNA-defined molecular phenotype improves clinically relevant stratification of head and neck cancer patients

2021 Clin Cancer Res. doi:10.1158/1078-0432.CCR-21-2244

Weber P, Kunstner A, Hess J, Unger K, Marschner S, Idel C, Ribbat-Idel J, Baumeister P, Gires O, Walz C, Rietzler S, Valeanu L, Herkommer T, Kreutzer L, Klymenko O, Drexler G, Kirchner T, Maihofer C, Ganswindt U, Walch A, Sterr M, Lickert H, Canis M, Rades D, Perner S, Berriel Diaz M, Herzig S, Lauber K, Wollenberg B, Busch H, Belka C, Zitzelsberger H

Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer

2019 Clin Cancer Res. doi:10.1158/1078-0432.CCR-18-0776

Hess J, Unger K, Maihoefer C, Schuttrumpf L, Wintergerst L, Heider T, Weber P, Marschner S, Braselmann H, Samaga D, Kuger S, Pflugradt U, Baumeister P, Walch A, Woischke C, Kirchner T, Werner M, Werner K, Baumann M, Budach V, Combs SE, Debus J, Grosu AL, Krause M, Linge A, Rodel C, Stuschke M, Zips D, Zitzelsberger H, Ganswindt U, Henke M, Belka C

A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection